Zinc in PDB 5yj0: Mouse Cereblon Thalidomide Binding Domain Complexed with S-Form Thalidomide
Protein crystallography data
The structure of Mouse Cereblon Thalidomide Binding Domain Complexed with S-Form Thalidomide, PDB code: 5yj0
was solved by
T.Mori,
T.Hakoshima,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
38.15 /
1.80
|
Space group
|
H 3 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
201.897,
201.897,
123.614,
90.00,
90.00,
120.00
|
R / Rfree (%)
|
18.9 /
20.4
|
Zinc Binding Sites:
Pages:
>>> Page 1 <<<
Page 2, Binding sites: 11 -
16;
Binding sites:
The binding sites of Zinc atom in the Mouse Cereblon Thalidomide Binding Domain Complexed with S-Form Thalidomide
(pdb code 5yj0). This binding sites where shown within
5.0 Angstroms radius around Zinc atom.
In total 16 binding sites of Zinc where determined in the
Mouse Cereblon Thalidomide Binding Domain Complexed with S-Form Thalidomide, PDB code: 5yj0:
Jump to Zinc binding site number:
1;
2;
3;
4;
5;
6;
7;
8;
9;
10;
Zinc binding site 1 out
of 16 in 5yj0
Go back to
Zinc Binding Sites List in 5yj0
Zinc binding site 1 out
of 16 in the Mouse Cereblon Thalidomide Binding Domain Complexed with S-Form Thalidomide
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 1 of Mouse Cereblon Thalidomide Binding Domain Complexed with S-Form Thalidomide within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn502
b:36.9
occ:1.00
|
SG
|
A:CYS329
|
2.3
|
34.2
|
1.0
|
SG
|
A:CYS394
|
2.3
|
29.5
|
1.0
|
SG
|
A:CYS326
|
2.3
|
26.0
|
1.0
|
SG
|
A:CYS397
|
2.3
|
29.4
|
1.0
|
CB
|
A:CYS394
|
3.3
|
28.0
|
1.0
|
CB
|
A:CYS329
|
3.3
|
35.9
|
1.0
|
CB
|
A:CYS326
|
3.3
|
31.8
|
1.0
|
CB
|
A:CYS397
|
3.4
|
36.8
|
1.0
|
N
|
A:CYS329
|
3.8
|
37.6
|
1.0
|
N
|
A:CYS397
|
3.8
|
32.8
|
1.0
|
OG1
|
A:THR332
|
4.1
|
35.9
|
1.0
|
CA
|
A:CYS329
|
4.1
|
35.2
|
1.0
|
CA
|
A:CYS397
|
4.2
|
32.7
|
1.0
|
CB
|
A:ILE396
|
4.5
|
33.7
|
1.0
|
CB
|
A:SER399
|
4.7
|
34.1
|
1.0
|
CB
|
A:GLN328
|
4.7
|
30.2
|
1.0
|
CA
|
A:CYS394
|
4.7
|
30.0
|
1.0
|
CA
|
A:CYS326
|
4.7
|
27.9
|
1.0
|
C
|
A:CYS397
|
4.8
|
35.0
|
1.0
|
C
|
A:GLN328
|
4.9
|
41.8
|
1.0
|
N
|
A:GLN330
|
4.9
|
34.5
|
1.0
|
C
|
A:CYS329
|
4.9
|
37.3
|
1.0
|
C
|
A:ILE396
|
4.9
|
37.7
|
1.0
|
N
|
A:ALA398
|
4.9
|
30.2
|
1.0
|
CG2
|
A:ILE396
|
5.0
|
35.9
|
1.0
|
|
Zinc binding site 2 out
of 16 in 5yj0
Go back to
Zinc Binding Sites List in 5yj0
Zinc binding site 2 out
of 16 in the Mouse Cereblon Thalidomide Binding Domain Complexed with S-Form Thalidomide
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 2 of Mouse Cereblon Thalidomide Binding Domain Complexed with S-Form Thalidomide within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:Zn502
b:36.5
occ:1.00
|
SG
|
D:CYS394
|
2.3
|
28.2
|
1.0
|
SG
|
D:CYS326
|
2.3
|
26.3
|
1.0
|
SG
|
D:CYS397
|
2.3
|
30.8
|
1.0
|
SG
|
D:CYS329
|
2.3
|
33.0
|
1.0
|
CB
|
D:CYS394
|
3.2
|
28.5
|
1.0
|
CB
|
D:CYS329
|
3.3
|
34.7
|
1.0
|
CB
|
D:CYS326
|
3.3
|
31.8
|
1.0
|
CB
|
D:CYS397
|
3.3
|
37.4
|
1.0
|
N
|
D:CYS397
|
3.8
|
33.4
|
1.0
|
N
|
D:CYS329
|
3.8
|
38.0
|
1.0
|
OG1
|
D:THR332
|
4.1
|
35.8
|
1.0
|
CA
|
D:CYS329
|
4.1
|
35.6
|
1.0
|
CA
|
D:CYS397
|
4.1
|
32.9
|
1.0
|
CB
|
D:ILE396
|
4.5
|
33.5
|
1.0
|
CB
|
D:SER399
|
4.7
|
30.9
|
1.0
|
CA
|
D:CYS394
|
4.7
|
29.8
|
1.0
|
CA
|
D:CYS326
|
4.7
|
27.9
|
1.0
|
CB
|
D:GLN328
|
4.8
|
31.0
|
1.0
|
C
|
D:CYS397
|
4.8
|
35.2
|
1.0
|
C
|
D:ILE396
|
4.9
|
37.5
|
1.0
|
N
|
D:ALA398
|
4.9
|
30.8
|
1.0
|
C
|
D:GLN328
|
4.9
|
42.3
|
1.0
|
N
|
D:GLN330
|
4.9
|
31.7
|
1.0
|
C
|
D:CYS329
|
4.9
|
37.2
|
1.0
|
|
Zinc binding site 3 out
of 16 in 5yj0
Go back to
Zinc Binding Sites List in 5yj0
Zinc binding site 3 out
of 16 in the Mouse Cereblon Thalidomide Binding Domain Complexed with S-Form Thalidomide
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 3 of Mouse Cereblon Thalidomide Binding Domain Complexed with S-Form Thalidomide within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
G:Zn502
b:36.4
occ:1.00
|
SG
|
G:CYS329
|
2.3
|
31.7
|
1.0
|
SG
|
G:CYS394
|
2.3
|
29.0
|
1.0
|
SG
|
G:CYS326
|
2.3
|
27.3
|
1.0
|
SG
|
G:CYS397
|
2.3
|
30.6
|
1.0
|
CB
|
G:CYS394
|
3.2
|
26.9
|
1.0
|
CB
|
G:CYS326
|
3.3
|
30.9
|
1.0
|
CB
|
G:CYS329
|
3.3
|
31.2
|
1.0
|
CB
|
G:CYS397
|
3.4
|
37.7
|
1.0
|
N
|
G:CYS397
|
3.8
|
32.0
|
1.0
|
N
|
G:CYS329
|
3.9
|
35.9
|
1.0
|
OG1
|
G:THR332
|
4.1
|
32.8
|
1.0
|
CA
|
G:CYS329
|
4.2
|
33.6
|
1.0
|
CA
|
G:CYS397
|
4.2
|
31.3
|
1.0
|
CB
|
G:ILE396
|
4.5
|
32.6
|
1.0
|
CB
|
G:SER399
|
4.7
|
33.0
|
1.0
|
CB
|
G:GLN328
|
4.7
|
31.6
|
1.0
|
CA
|
G:CYS394
|
4.7
|
27.5
|
1.0
|
CA
|
G:CYS326
|
4.7
|
28.1
|
1.0
|
C
|
G:CYS397
|
4.8
|
32.8
|
1.0
|
C
|
G:GLN328
|
4.8
|
40.2
|
1.0
|
N
|
G:GLN330
|
4.9
|
32.1
|
1.0
|
C
|
G:CYS329
|
4.9
|
36.8
|
1.0
|
C
|
G:ILE396
|
4.9
|
35.5
|
1.0
|
N
|
G:ALA398
|
4.9
|
28.8
|
1.0
|
CG2
|
G:ILE396
|
5.0
|
33.3
|
1.0
|
|
Zinc binding site 4 out
of 16 in 5yj0
Go back to
Zinc Binding Sites List in 5yj0
Zinc binding site 4 out
of 16 in the Mouse Cereblon Thalidomide Binding Domain Complexed with S-Form Thalidomide
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 4 of Mouse Cereblon Thalidomide Binding Domain Complexed with S-Form Thalidomide within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
J:Zn502
b:25.4
occ:1.00
|
SG
|
J:CYS329
|
2.3
|
20.5
|
1.0
|
SG
|
J:CYS394
|
2.3
|
18.9
|
1.0
|
SG
|
J:CYS397
|
2.3
|
19.2
|
1.0
|
SG
|
J:CYS326
|
2.3
|
19.6
|
1.0
|
CB
|
J:CYS326
|
3.2
|
18.0
|
1.0
|
CB
|
J:CYS394
|
3.2
|
17.8
|
1.0
|
CB
|
J:CYS329
|
3.3
|
23.1
|
1.0
|
CB
|
J:CYS397
|
3.4
|
23.0
|
1.0
|
N
|
J:CYS329
|
3.8
|
22.2
|
1.0
|
N
|
J:CYS397
|
3.9
|
16.6
|
1.0
|
CA
|
J:CYS329
|
4.1
|
20.5
|
1.0
|
CA
|
J:CYS397
|
4.2
|
19.1
|
1.0
|
CB
|
J:ILE396
|
4.5
|
23.6
|
1.0
|
CA
|
J:CYS326
|
4.6
|
19.3
|
1.0
|
OG1
|
J:THR332
|
4.6
|
22.2
|
1.0
|
CB
|
J:THR332
|
4.6
|
21.4
|
1.0
|
CB
|
J:GLN328
|
4.6
|
19.1
|
1.0
|
CA
|
J:CYS394
|
4.7
|
16.4
|
1.0
|
OG
|
J:SER399
|
4.8
|
26.0
|
1.0
|
CB
|
J:SER399
|
4.8
|
22.7
|
1.0
|
C
|
J:GLN328
|
4.9
|
25.2
|
1.0
|
C
|
J:ILE396
|
4.9
|
24.3
|
1.0
|
C
|
J:CYS397
|
4.9
|
23.3
|
1.0
|
C
|
J:CYS326
|
5.0
|
19.5
|
1.0
|
C
|
J:CYS329
|
5.0
|
21.6
|
1.0
|
CG2
|
J:ILE396
|
5.0
|
23.3
|
1.0
|
|
Zinc binding site 5 out
of 16 in 5yj0
Go back to
Zinc Binding Sites List in 5yj0
Zinc binding site 5 out
of 16 in the Mouse Cereblon Thalidomide Binding Domain Complexed with S-Form Thalidomide
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 5 of Mouse Cereblon Thalidomide Binding Domain Complexed with S-Form Thalidomide within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
M:Zn502
b:30.7
occ:1.00
|
SG
|
M:CYS394
|
2.3
|
22.1
|
1.0
|
SG
|
M:CYS329
|
2.3
|
26.7
|
1.0
|
SG
|
M:CYS397
|
2.3
|
23.9
|
1.0
|
SG
|
M:CYS326
|
2.3
|
23.6
|
1.0
|
CB
|
M:CYS394
|
3.2
|
24.1
|
1.0
|
CB
|
M:CYS326
|
3.2
|
20.9
|
1.0
|
CB
|
M:CYS329
|
3.3
|
31.5
|
1.0
|
CB
|
M:CYS397
|
3.4
|
25.3
|
1.0
|
N
|
M:CYS329
|
3.7
|
28.1
|
1.0
|
N
|
M:CYS397
|
3.9
|
26.4
|
1.0
|
CA
|
M:CYS329
|
4.1
|
27.1
|
1.0
|
CA
|
M:CYS397
|
4.2
|
25.8
|
1.0
|
CB
|
M:ILE396
|
4.4
|
29.0
|
1.0
|
OG1
|
M:THR332
|
4.6
|
25.6
|
1.0
|
CB
|
M:GLN328
|
4.6
|
25.0
|
1.0
|
CA
|
M:CYS326
|
4.7
|
21.5
|
1.0
|
CA
|
M:CYS394
|
4.7
|
25.1
|
1.0
|
CB
|
M:THR332
|
4.7
|
27.1
|
1.0
|
CB
|
M:SER399
|
4.8
|
31.0
|
1.0
|
C
|
M:GLN328
|
4.8
|
30.0
|
1.0
|
C
|
M:ILE396
|
4.8
|
30.7
|
1.0
|
CG2
|
M:ILE396
|
4.9
|
31.8
|
1.0
|
C
|
M:CYS397
|
4.9
|
29.0
|
1.0
|
C
|
M:CYS329
|
5.0
|
28.7
|
1.0
|
|
Zinc binding site 6 out
of 16 in 5yj0
Go back to
Zinc Binding Sites List in 5yj0
Zinc binding site 6 out
of 16 in the Mouse Cereblon Thalidomide Binding Domain Complexed with S-Form Thalidomide
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 6 of Mouse Cereblon Thalidomide Binding Domain Complexed with S-Form Thalidomide within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
P:Zn502
b:27.0
occ:1.00
|
SG
|
P:CYS394
|
2.3
|
20.8
|
1.0
|
SG
|
P:CYS326
|
2.3
|
22.0
|
1.0
|
SG
|
P:CYS329
|
2.3
|
22.1
|
1.0
|
SG
|
P:CYS397
|
2.3
|
21.7
|
1.0
|
CB
|
P:CYS394
|
3.2
|
19.6
|
1.0
|
CB
|
P:CYS326
|
3.2
|
19.5
|
1.0
|
CB
|
P:CYS329
|
3.2
|
22.0
|
1.0
|
CB
|
P:CYS397
|
3.4
|
23.3
|
1.0
|
N
|
P:CYS329
|
3.8
|
22.6
|
1.0
|
N
|
P:CYS397
|
3.8
|
22.5
|
1.0
|
CA
|
P:CYS329
|
4.1
|
20.3
|
1.0
|
CA
|
P:CYS397
|
4.1
|
22.2
|
1.0
|
CB
|
P:ILE396
|
4.5
|
20.9
|
1.0
|
CB
|
P:SER399
|
4.6
|
23.2
|
1.0
|
OG1
|
P:THR332
|
4.6
|
25.1
|
1.0
|
CB
|
P:THR332
|
4.6
|
26.4
|
1.0
|
CA
|
P:CYS394
|
4.7
|
21.2
|
1.0
|
CA
|
P:CYS326
|
4.7
|
18.6
|
1.0
|
CB
|
P:GLN328
|
4.7
|
22.1
|
1.0
|
C
|
P:ILE396
|
4.7
|
25.5
|
1.0
|
C
|
P:CYS397
|
4.8
|
26.6
|
1.0
|
C
|
P:GLN328
|
4.9
|
21.9
|
1.0
|
N
|
P:ALA398
|
4.9
|
24.0
|
1.0
|
C
|
P:CYS329
|
4.9
|
20.5
|
1.0
|
N
|
P:SER399
|
5.0
|
20.4
|
1.0
|
N
|
P:ILE396
|
5.0
|
20.2
|
1.0
|
CA
|
P:ILE396
|
5.0
|
21.4
|
1.0
|
|
Zinc binding site 7 out
of 16 in 5yj0
Go back to
Zinc Binding Sites List in 5yj0
Zinc binding site 7 out
of 16 in the Mouse Cereblon Thalidomide Binding Domain Complexed with S-Form Thalidomide
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 7 of Mouse Cereblon Thalidomide Binding Domain Complexed with S-Form Thalidomide within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
S:Zn502
b:27.4
occ:1.00
|
SG
|
S:CYS329
|
2.3
|
21.9
|
1.0
|
SG
|
S:CYS394
|
2.3
|
20.4
|
1.0
|
SG
|
S:CYS326
|
2.3
|
21.6
|
1.0
|
SG
|
S:CYS397
|
2.3
|
21.4
|
1.0
|
CB
|
S:CYS394
|
3.2
|
20.9
|
1.0
|
CB
|
S:CYS326
|
3.2
|
18.6
|
1.0
|
CB
|
S:CYS329
|
3.3
|
21.7
|
1.0
|
CB
|
S:CYS397
|
3.4
|
22.2
|
1.0
|
N
|
S:CYS329
|
3.8
|
24.0
|
1.0
|
N
|
S:CYS397
|
3.8
|
22.8
|
1.0
|
CA
|
S:CYS329
|
4.1
|
22.0
|
1.0
|
CA
|
S:CYS397
|
4.1
|
23.4
|
1.0
|
CB
|
S:ILE396
|
4.5
|
20.3
|
1.0
|
CB
|
S:SER399
|
4.5
|
23.9
|
1.0
|
OG1
|
S:THR332
|
4.6
|
23.8
|
1.0
|
CB
|
S:THR332
|
4.6
|
24.5
|
1.0
|
CB
|
S:GLN328
|
4.6
|
21.1
|
1.0
|
CA
|
S:CYS394
|
4.7
|
21.1
|
1.0
|
CA
|
S:CYS326
|
4.7
|
17.9
|
1.0
|
C
|
S:CYS397
|
4.7
|
25.4
|
1.0
|
C
|
S:ILE396
|
4.8
|
24.3
|
1.0
|
C
|
S:GLN328
|
4.9
|
23.0
|
1.0
|
N
|
S:ALA398
|
4.9
|
23.4
|
1.0
|
N
|
S:SER399
|
4.9
|
21.6
|
1.0
|
C
|
S:CYS329
|
5.0
|
21.6
|
1.0
|
N
|
S:ILE396
|
5.0
|
19.9
|
1.0
|
CG2
|
S:ILE396
|
5.0
|
24.7
|
1.0
|
CA
|
S:ILE396
|
5.0
|
21.5
|
1.0
|
|
Zinc binding site 8 out
of 16 in 5yj0
Go back to
Zinc Binding Sites List in 5yj0
Zinc binding site 8 out
of 16 in the Mouse Cereblon Thalidomide Binding Domain Complexed with S-Form Thalidomide
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 8 of Mouse Cereblon Thalidomide Binding Domain Complexed with S-Form Thalidomide within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
V:Zn502
b:26.0
occ:1.00
|
SG
|
V:CYS329
|
2.3
|
20.5
|
1.0
|
SG
|
V:CYS394
|
2.3
|
18.1
|
1.0
|
SG
|
V:CYS397
|
2.3
|
19.2
|
1.0
|
SG
|
V:CYS326
|
2.3
|
19.9
|
1.0
|
CB
|
V:CYS326
|
3.2
|
18.4
|
1.0
|
CB
|
V:CYS394
|
3.2
|
17.1
|
1.0
|
CB
|
V:CYS329
|
3.3
|
20.6
|
1.0
|
CB
|
V:CYS397
|
3.4
|
23.7
|
1.0
|
N
|
V:CYS329
|
3.8
|
22.6
|
1.0
|
N
|
V:CYS397
|
3.9
|
17.5
|
1.0
|
CA
|
V:CYS329
|
4.1
|
19.3
|
1.0
|
CA
|
V:CYS397
|
4.2
|
19.8
|
1.0
|
CB
|
V:ILE396
|
4.5
|
22.4
|
1.0
|
OG1
|
V:THR332
|
4.6
|
20.3
|
1.0
|
CA
|
V:CYS326
|
4.6
|
19.7
|
1.0
|
CB
|
V:THR332
|
4.6
|
19.9
|
1.0
|
CB
|
V:GLN328
|
4.6
|
20.5
|
1.0
|
CA
|
V:CYS394
|
4.7
|
15.8
|
1.0
|
OG
|
V:SER399
|
4.8
|
25.9
|
1.0
|
CB
|
V:SER399
|
4.8
|
23.4
|
1.0
|
C
|
V:GLN328
|
4.9
|
24.1
|
1.0
|
C
|
V:ILE396
|
4.9
|
24.5
|
1.0
|
C
|
V:CYS397
|
4.9
|
23.6
|
1.0
|
C
|
V:CYS326
|
4.9
|
19.4
|
1.0
|
|
Zinc binding site 9 out
of 16 in 5yj0
Go back to
Zinc Binding Sites List in 5yj0
Zinc binding site 9 out
of 16 in the Mouse Cereblon Thalidomide Binding Domain Complexed with S-Form Thalidomide
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 9 of Mouse Cereblon Thalidomide Binding Domain Complexed with S-Form Thalidomide within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
Y:Zn502
b:30.6
occ:1.00
|
SG
|
Y:CYS329
|
2.3
|
27.5
|
1.0
|
SG
|
Y:CYS394
|
2.3
|
22.9
|
1.0
|
SG
|
Y:CYS397
|
2.3
|
23.6
|
1.0
|
SG
|
Y:CYS326
|
2.3
|
24.2
|
1.0
|
CB
|
Y:CYS394
|
3.2
|
24.6
|
1.0
|
CB
|
Y:CYS326
|
3.2
|
22.5
|
1.0
|
CB
|
Y:CYS329
|
3.3
|
31.6
|
1.0
|
CB
|
Y:CYS397
|
3.4
|
26.9
|
1.0
|
N
|
Y:CYS329
|
3.7
|
29.2
|
1.0
|
N
|
Y:CYS397
|
3.8
|
26.3
|
1.0
|
CA
|
Y:CYS329
|
4.1
|
26.4
|
1.0
|
CA
|
Y:CYS397
|
4.2
|
27.6
|
1.0
|
CB
|
Y:ILE396
|
4.4
|
27.9
|
1.0
|
OG1
|
Y:THR332
|
4.5
|
27.5
|
1.0
|
CB
|
Y:GLN328
|
4.6
|
23.3
|
1.0
|
CA
|
Y:CYS394
|
4.7
|
26.0
|
1.0
|
CB
|
Y:THR332
|
4.7
|
27.4
|
1.0
|
CA
|
Y:CYS326
|
4.7
|
24.4
|
1.0
|
C
|
Y:GLN328
|
4.8
|
29.7
|
1.0
|
CG2
|
Y:ILE396
|
4.8
|
33.4
|
1.0
|
C
|
Y:ILE396
|
4.8
|
30.6
|
1.0
|
C
|
Y:CYS397
|
4.9
|
29.4
|
1.0
|
CB
|
Y:SER399
|
4.9
|
30.0
|
1.0
|
C
|
Y:CYS329
|
5.0
|
27.2
|
1.0
|
N
|
Y:ALA398
|
5.0
|
24.0
|
1.0
|
|
Zinc binding site 10 out
of 16 in 5yj0
Go back to
Zinc Binding Sites List in 5yj0
Zinc binding site 10 out
of 16 in the Mouse Cereblon Thalidomide Binding Domain Complexed with S-Form Thalidomide
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 10 of Mouse Cereblon Thalidomide Binding Domain Complexed with S-Form Thalidomide within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
b:Zn502
b:27.4
occ:1.00
|
SG
|
b:CYS394
|
2.3
|
20.7
|
1.0
|
SG
|
b:CYS329
|
2.3
|
21.6
|
1.0
|
SG
|
b:CYS326
|
2.3
|
21.8
|
1.0
|
SG
|
b:CYS397
|
2.3
|
22.4
|
1.0
|
CB
|
b:CYS394
|
3.2
|
20.8
|
1.0
|
CB
|
b:CYS326
|
3.2
|
18.7
|
1.0
|
CB
|
b:CYS329
|
3.3
|
23.6
|
1.0
|
CB
|
b:CYS397
|
3.4
|
22.7
|
1.0
|
N
|
b:CYS329
|
3.8
|
22.6
|
1.0
|
N
|
b:CYS397
|
3.8
|
22.5
|
1.0
|
CA
|
b:CYS329
|
4.1
|
22.2
|
1.0
|
CA
|
b:CYS397
|
4.1
|
22.9
|
1.0
|
CB
|
b:SER399
|
4.5
|
23.2
|
1.0
|
CB
|
b:ILE396
|
4.5
|
21.2
|
1.0
|
OG1
|
b:THR332
|
4.6
|
23.1
|
1.0
|
CB
|
b:THR332
|
4.6
|
24.9
|
1.0
|
CB
|
b:GLN328
|
4.6
|
20.8
|
1.0
|
CA
|
b:CYS394
|
4.6
|
20.8
|
1.0
|
CA
|
b:CYS326
|
4.7
|
19.4
|
1.0
|
C
|
b:CYS397
|
4.8
|
26.4
|
1.0
|
C
|
b:ILE396
|
4.8
|
25.6
|
1.0
|
C
|
b:GLN328
|
4.8
|
22.1
|
1.0
|
N
|
b:ALA398
|
4.9
|
23.0
|
1.0
|
N
|
b:SER399
|
4.9
|
20.5
|
1.0
|
C
|
b:CYS329
|
5.0
|
20.4
|
1.0
|
N
|
b:ILE396
|
5.0
|
20.3
|
1.0
|
|
Reference:
T.Mori,
T.Ito,
S.Liu,
H.Ando,
S.Sakamoto,
Y.Yamaguchi,
E.Tokunaga,
N.Shibata,
H.Handa,
T.Hakoshima.
Structural Basis of Thalidomide Enantiomer Binding to Cereblon Sci Rep V. 8 1294 2018.
ISSN: ESSN 2045-2322
PubMed: 29358579
DOI: 10.1038/S41598-018-19202-7
Page generated: Mon Oct 28 15:47:15 2024
|